Tumor-Derived Lactate Modifies Antitumor Immune Response: Effect on Myeloid-Derived Suppressor Cells and NK Cells
暂无分享,去创建一个
[1] A. Mackensen,et al. Tumor metabolism as modulator of immune response and tumor progression. , 2012, Seminars in cancer biology.
[2] Bin Hu,et al. Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c‐Jun activation , 2012, International journal of cancer.
[3] T. Seyfried,et al. Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer? , 2012, Epilepsy Research.
[4] P. Sinha,et al. Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC) , 2012, Cancer Immunology, Immunotherapy.
[5] J. Olefsky,et al. The cellular and signaling networks linking the immune system and metabolism in disease , 2012, Nature Medicine.
[6] J. Koutcher,et al. Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment. , 2012, Experimental cell research.
[7] M. Manns,et al. Myeloid derived suppressor cells in human diseases. , 2011, International immunopharmacology.
[8] M. Manns,et al. Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. , 2011, Blood.
[9] V. Bronte,et al. Transcription factors in myeloid-derived suppressor cell recruitment and function. , 2011, Current opinion in immunology.
[10] J. Rathmell,et al. Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.
[11] A. Chawla,et al. Alternative macrophage activation and metabolism. , 2011, Annual review of pathology.
[12] D. Mathis,et al. Immunometabolism: an emerging frontier , 2011, Nature Reviews Immunology.
[13] R. Lenkinski,et al. On-target inhibition of tumor fermentative glycolysis as visualized by hyperpolarized pyruvate. , 2011, Neoplasia.
[14] D. Gabrilovich,et al. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. , 2011, Trends in immunology.
[15] S. Bicciato,et al. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. , 2010, Immunity.
[16] L. Cantley,et al. Altered metabolism in cancer , 2010, BMC Biology.
[17] V. Bronte,et al. Myeloid-derived suppressor cell heterogeneity and subset definition. , 2010, Current opinion in immunology.
[18] W. Linehan,et al. LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer , 2009, Molecular Cancer Therapeutics.
[19] Srinivas Nagaraj,et al. Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.
[20] I. Borrello,et al. Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. , 2008, Cancer research.
[21] L. Zitvogel,et al. The anticancer immune response: indispensable for therapeutic success? , 2008, The Journal of clinical investigation.
[22] H. Shime,et al. Tumor-Secreted Lactic Acid Promotes IL-23/IL-17 Proinflammatory Pathway1 , 2008, The Journal of Immunology.
[23] A. Mackensen,et al. Tumor-induced modulation of dendritic cell function. , 2008, Cytokine & growth factor reviews.
[24] S. Pizzo,et al. Carbohydrate restriction, prostate cancer growth, and the insulin‐like growth factor axis , 2008, The Prostate.
[25] R. Deberardinis,et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.
[26] D. Tuveson,et al. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. , 2007, Cancer research.
[27] Gregor Rothe,et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. , 2007, Blood.
[28] M. Smyth,et al. Immune surveillance of tumors. , 2007, The Journal of clinical investigation.
[29] M. Kiebish,et al. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer , 2007, Nutrition & metabolism.
[30] P. Dahm,et al. Reversal of Tumor-Mediated Immunosuppression , 2007, Clinical Cancer Research.
[31] B. Han,et al. Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies? , 2006, Cancer and Metastasis Reviews.
[32] A. Mackensen,et al. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. , 2006, Blood.
[33] R. Gillies,et al. Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.
[34] R. Schreiber,et al. Cancer immunoediting: from immunosurveillance to tumor escape , 2002, Nature Immunology.
[35] M. Dewhirst,et al. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. , 2001, International journal of radiation oncology, biology, physics.
[36] W. Kreutz,et al. Acidic pH inhibits non-MHC-restricted killer cell functions. , 2000, Clinical immunology.
[37] H. Lyng,et al. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. , 1997, The American journal of pathology.
[38] E. Podack,et al. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. , 1996, Journal of immunology.
[39] P. Okunieff,et al. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.
[40] M. Young,et al. Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. , 1987, Cancer research.
[41] Otto Warburn,et al. THE METABOLISM OF TUMORS , 1931 .